Part B: Supplementary Information Sheet (SIS) |
FR Recognition List Number
|
051
|
Date of Entry 01/14/2019
|
FR Recognition Number
|
7-285
|
Standard | |
CLSI M48-A 2nd Edition Laboratory Detection and Identification of Mycobacteria |
|
Scope/AbstractThis standard addresses topics related to the laboratory diagnosis of mycobacterial infections including safety and related issues, levels of service and referrals, clinical significance of mycobacteria, acceptable specimen types and their collection, transport and storage, specimen processing methods, methods for the direct detection of mycobacteria in clinical specimens, culture methods including contamination issues, reporting and quality control, and phenotypic and genotypic identification procedures. |
|
Extent of Recognition
|
Rationale for Recognition
This standard is relevant to medical devices and is recognized on its scientific and technical merit and/or because it supports existing regulatory policies. |
|
Public Law, CFR Citation(s) and Procode(s)*
Regulation Number |
Device Name |
Device Class |
Product Code |
§866.2660 |
Kit, Identification, Mycobacteria
|
Class 1
|
JSY
|
§866.3370 |
Antiserum, Fluorescent, Mycobacterium Tuberculosis
|
Class 1
|
GRT
|
§866.3370 |
Dna-Reagents, Mycobacterium Spp.
|
Class 1
|
LQF
|
§866.3370 |
Assay, Nucleic Acid Amplification, Growth Identification, Mycobacterium Tuberculosis
|
Class 1
|
NDZ
|
§866.3370 |
System, Mycolic Acid Analysis, Mycobacterium Tuberculosis
|
Class 1
|
NJO
|
|
|
|
|
|
Relevant FDA Guidance and/or Supportive Publications*
Appropriate Use of Voluntary Consensus Standards in Premarket Submissions for Medical Devices - Guidance for Industry and Food and Drug Administration Staff, issued September 2018. |
|
FDA Technical Contact
|
Standards Development Organization
|
FDA Specialty Task Group (STG)
|
*These are provided as examples and others may be applicable. |